The Effect of Carotid Calcification on Outcomes of Transfemoral and Transcarotid Artery Stenting in the VQI Michael neilson, MD1 Mahmoud malas, MD, MHS2.

Slides:



Advertisements
Similar presentations
Prevalence and Predictors of Off-label Use of Cardiac Resynchronization Therapy: A Report from the ICD Registry TM Adam S. Fein * MD, Yongfei Wang ¥ MS,
Advertisements

Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
1 CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Impact of Anticoagulant and Anti-platelet Therapy on ICD Implant-Related Bleeding and Thromboembolic Events in Patients Enrolled in the NCDR ® ICD Registry.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Factors influencing treatment decisions for coronary artery disease after cardiac catheterization American Heart Association November 18, 2013 Dallas,
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
PPAR  activation Clinical evidence. Evolution of clinical evidence supporting PPAR  activation and beyond Surrogate outcomes studies Large.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Basel Stent Cost-Effectiveness (BASKET) Trial BASKET Trial Presented at The European Society of Cardiology Hotline Session 2005 Presented by Dr. Matthias.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.
ISAR-CABG Objective To compare the efficacy of DES with BMS in a randomized trial powered for clinical events Sample 610 patients with de novo SVG lesions.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Impact Of Diabetes Mellitus On The Safety And Effectiveness Of Bivalirudin In Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty:
○ South Asians (SAs) have high rates of CHD which are not entirely explained by traditional CVD risk factors. ○ The association of a family history of.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Disclosures Runlin Gao has received a research grant
Single IMA {Single Arterial}
Runlin Gao, M.D. On behalf of ABSORB China Investigators
European Society of Cardiology 2017 Clinical Trial Update I
Carotid Artery Stenosis
Heart Valve Thrombosis & Neuro-Outcomes
PCI related in-hospital mortality based on race and gender in the USA
Larissa Registry on CAS and CEA:
Procedural factors associated with PCI-related ischemic stroke
Cardiovascular Research Technology Conference (CRT 17)
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
LDL Cholesterol Lowering with Evolocumab and Outcomes in Patients with Peripheral Artery Disease: Insights from the FOURIER Trial Marc P. Bonaca, Patrice.
MACE Trial Rationale, Study Design, and Current Status
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Risk of Stroke or Death Is Associated With the Timing of Carotid Artery Stenting for Symptomatic Carotid Stenosis: A Secondary Data Analysis of the German.
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Cardiovacular Research Technologies
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Section 5: Intervention and drug therapy
Beta-blocker use is associated with lower stroke and death after carotid artery stenting  Tammam Obeid, MBBS, Isibor Arhuidese, MBBS, MPH, Alicia Gaidry,
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative  Mahmoud.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index.
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Stephen J. Nicholls, MBBS, PhD; E
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Long Term Clinical Results from the Endeavor Program: 5-Year Follow up
Maintenance of Long-Term Clinical Benefit with
VESS05. In-Hospital Outcomes of Transcarotid Artery Revascularization and Carotid Endarterectomy in the Society for Vascular Surgery Vascular Quality.
Association between the choice of anesthesia and in-hospital outcomes after carotid artery stenting  Hanaa Dakour-Aridi, MD, Muhammad Rizwan, MD, Besma.
Transcarotid Artery Revascularization
Larger Sheath Size for Infrainguinal Endovascular Intervention is Associated with Minor but Not Major Morbidity or Mortality Scott R. Levin MD, Alik.
Emily L. Spangler, MD, MS, Philip P
Is TCAR best under LA or GA
Influence of Hospital Volume on Outcomes of Thoracic Endovascular Repair in Vascular Quality Initiative Database: 5-year National Study. Presenting Author:
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Repair of Small Ruptured AAA in the VQI
Massachusetts General Hospital
Presentation transcript:

The Effect of Carotid Calcification on Outcomes of Transfemoral and Transcarotid Artery Stenting in the VQI Michael neilson, MD1 Mahmoud malas, MD, MHS2 Grace wang, MD3 Vikram Kashyap, MD4 Raghu motaganahalli, MBBS4 Marc Schermerhorn, MD5 Jack cronenwett, MD6 Jens Eldrup-Jorgensen, MD1 Brian Nolan, MD1 1-Maine Medical Center, 2-UCSD, 3-UPENN, 4 Indiana University, 5- Beth Israel Deconess, 6-Dartmouth

No disclosures

1 Introduction Carotid artery calcification has been previously reported as a risk factor for post-operative neurologic outcomes following transfemoral carotid stenting (TF-CAS).1 Transcarotid Artery Revascularization (TCAR) has been shown to be safe and effective treatment of carotid stenosis, especially in otherwise high risk individuals.2 1.AbuRahma AF, DerDerian T, Hairi N et al. Anatomic and technical predictors of perioperative clinical outcomes after carotid artery stenting. J Vasc Surg. 2017;66(2): 423-432. 2. Wang Sk, Fajardo A, Sawchuk AP, et al. Outcomes associated with Transcarotid artery revascularization-centered protocol in high risk carotid revascularization using the ENROUE neuroprotection system. J Vasc Surg. 2019;69(3):807-813.

Carotid Calcification in VQI Reported since 2016 Subjective report of degree of calcification of carotid lesion Reported as degree of circumferential calcification <25%, 25-50%, 51-99%, 100% Since 2016 the degree of calcification of the target lesion has been reported to the VQI. This is done in four ranges, ie < 25%, 25-50%, 51-99% or 100% circumferential calcification.

Objective Compare outcomes of TF-CAS and TCAR stratified by degree of circumferential carotid calcification in the VQI

Methods Retrospective cohort study of all CAS in the VQI, 2016-2019 Analyzed by degree of calcification <25%, 25-50%, 51-99%, 100% Primary endpoint Stroke occurring during index hospitalization Secondary Endpoints Major adverse cardiac events (MACE), hemodynamic suppression Multivariate logistic regression analysis to predict carotid calcification MACE included MI, dysrhythmia, or CHF while hemodynamic suppression included hypotension or bradycardia Multivariate logistic regression was used to identify risk factors for carotid calcification

Results Carotid Stenting in VQI, 2016-2019 N=4834 (n=1890) (n=2944) 39% (n=1890) 61% (n=2944) Between 2016 and 2019 there were 4,834 CAS procedures done in the VQI, 61% were TF with 39% being TCAR

Degree of Calicification Patient Demographics Degree of Calicification   <=25% (n=2400) 26-50% (n=885) 51-99% (n=1,361) 100% (n=188) p-value Age 68 71 72 73 0.022 Female 35% 34% 37% 43% 0.050 Symptomatic (stroke or TIA) 61% 64% 60% 0.409 Primary lesion 70% 86% 87% 88% 0.001 Hypertension 84% 91% MI or agina 25% 26% 30% 23% 0.006 Prior PCI or CABG 32% 40% Prior dysrhythmia 16% 20% 24% CHF 14% 19% Current smoker 38% 39% 0.971 COPD 28% 29% 27% ESRD 1% 2% 0.162 Current ASA 83% 85% Current P2Y 73% 78% 80% 71% Current statin Triple therapy 58% 63% 66% Non-white race 13% 10% 9% 0.015 Patient demographics stratified by degree of calcification showed a high burden of traditional risk factors for atherosclerosis, there appeared to be an association between increases degrees of calfication and age, female sex, CHF, and primary lesion as opposed to redo lesion. Increasing degrees of calcification was not associated with symptom status.

Primary Outcomes TCAR p= 0.943 TF-CAS p< 0.001 In terms of our primary outcome, in the tF-CAS cohort there was a statistically significant increasing risk of post-operative neurologic event in those with increasing degree of calcification with a a rate of 2.2% in those with minimal calcification, up to 9.3% in those with 100% calcification. In contrast, those in the TCAR group had no statistically significant deifference in neurologic outcome based on degree of calcification, with a range of 1.2&% to 2.3%. TCAR p= 0.943 TF-CAS p< 0.001

Secondary Outcomes TF-CAS p< 0.001 TCAR p < 0.001 Patients with minimal rates of calcification in the TF-CAS had minimal rates of hemodynamic suppression, while those in the TCAR cohort had increasing rates of hemodynamic suppression with increasing rates of calcification. TF-CAS p< 0.001 TCAR p < 0.001 ** Hypotension and/or bradycardia

Secondary Outcomes TF-CAS p = 0.21 TCAR p = 0.02 Those undergoing TF-CAS had a trend towards increasing MACE for increasing degrees of calcification, though this was not statistically significant. TF-CAS p = 0.21 TCAR p = 0.02

Predictors of Carotid Calcification   OR p value 95% CI Age > 80 2.22 0.001 1.80 2.74 Ae 70 to 79 1.69 1.41 2.03 Age 60 to 69 1.42 1.178 1.714 Atherosclerotic lesion 2.67 2.28 3.10 COPD 1.34 1.17 1.53 CHF 1.27 0.004 1.08 1.51 HTN 1.33 0.002 1.12 1.61 Prior CABG or PCI 1.13 0.048 1.01 1.30 Diabetes 0.015 1.03 Non white race 0.74 0.614 0.90 On multivariate logistric regression, increasing age, as well as a number of co-morbidities including atherosclerotic lesion, COPD< CHF, HTN, prior cardiac intervention and diabetes were also associated with carotic calcification. Non-white race was inversley associated with carotid calcification.

Limitations Self reported degree of calcification within VQI, not adjudicated Retrospective in nature, can only show association, not causation

Summary Increasing degree of calcification is associated with increasing rates of post-operative CVA following TF-CAS This is not seen after TCAR Rate of hemodynamic suppression increases with increasing calcification following both procedures, particularly following TCAR, but this needs further investigation Multiple risk factors for increasing degree of carotid calcification Multiple risk factors for increasing degrees of calcification which may

Conclusions TCAR may be an acceptable alternative even in patients with extensive calcification, though with caution Can predict possibility of carotid calcification which may effect treatment type and pre-operative imaging TCAR may be an acceptable alternative even in patients with extensive calcification, though caution must be taken in regards to possible hemodynamic suppression Further research is needed in the form of a prospective trial to fully elucidate the relationship between carotid calcification and post operative events when considering CAS

Thank You

Degree of Calicification Outcomes Transfemoral Degree of Calicification   <=25% (n=1568) 26-50% (n=512) 51-99% (n=757) 100% (n=107) p-value Postop Neuro event 2.2% 2.9% 4.4% 9.3% 0.001 Postop Hypotension 12% 17% 16% 0.015 Bradycardia 11% 15% 0.034 HD suppression 20% 26% 25% 23% 0.010 Cardiac event 2.8% 2.1% 5.6% 0.21 TCAR <=25% (n=832) 26-50% (n=373) 51-99% (n=604) 100% (n=81) Postop neuro event 2.3% 1.2% 0.943 Postop hypotension 0.004 10% 13% 0.139 21% 39% Postop cardiac event 2.4% 0.3% 2.6% 0.02 In terms of our primary outcome, in the tF-CAS cohort there was a statistically significant increasing risk of post-operative neurologic event in those with increasing degree of calcification with a a rate of 2.2% in those with minimal calcification, up to 9.3% in those with 100% calcification. In contrast, those in the TCAR group had no statistically significant deifference in neurologic outcome based on degree of calcification, with a range of 1.2&% to 2.3%.

Results P=0.001 P=0.001 P=0.04 P=0.253 There was a statistically significant difference between types of interventions at all levels of calcification except at 100% calcification.

Results: Procedural Details Degree of Calicification   <=25% (n=2400) 26-50% (n=885) 51-99% (n=1,361) 100% (n=188) Pre and postdilate 30% 28% 24% 25% Pre dilate only 6% 5% 7% Post dilate 65% 68% 69% 70% The details of the procedure showed that there was an increasing use of post dilation balloon use with increasing degrees of calcification, which was statistically significant. P=.0011